NPPA issued a notification regarding the fixation of the retail price of Teneligliptin Hydrochloride Hydrate IP, eq. to Teneligliptin 20 mg + Dapagliflozin Propanediol Monohydrate, eq. to Dapagliflozin 10 mg + Metformin Hydrochloride I.P 500 mg

Nov 13, 2025 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on November 12, 2025, issued a notification regarding the fixation of the retail price of Teneligliptin Hydrochloride Hydrate IP, eq. to Teneligliptin 20 mg + Dapagliflozin Propanediol Monohydrate, eq. to Dapagliflozin 10 mg + Metformin Hydrochloride I.P 500 mg.

The following has been stated: -

•For each film-coated bilayer tablet contains: Teneligliptin Hydrochloride Hydrate IP eq. to Teneligliptin 20 mg + Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10 mg + Metformin Hydrochloride I.P 500 mg (As Sustained Release) for M/s Synokem Pharmaceuticals Ltd. (Manufacturer) & M/s Glenmark Pharmaceuticals Ltd. (Marketer), the retail price is 12.15 (Rs).


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT